Exploristics Clinical Data Analysis and Modelling
At Exploristics we provide innovative analysis solutions to maximise the information derived from your clinical data. We offer a unique expertise in the exploratory analysis and clinical application of biomarkers, pharmacogenomics, imaging and observational data.
The team at Exploristics offers more than a statistical analysis and reporting service. We take pride in using our analytical skills and scientific expertise to help you make informed decisions. We work closely with our customers to understand their data analysis needs and to provide practical solutions. So far, we have worked successfully with pharmaceutical, biotechnology, medical diagnostics and devices companies as well as healthcare providers. Our service is friendly and cost-effective and our work is compliant with GCP / ICH guidelines.
Clinical data exploration, mining and modelling
Our broad experience using multiple analysis techniques enables us to perform a wide range of exploratory data analyses. These allow us to gain a thorough understanding of the data and to detect meaningful patterns in the data.
Furthermore, we can develop mathematical models that describe complex processes and then study the behaviour of those models under different conditions. This approach can save time and money by allowing you to evaluate your options by running virtual experiments. These methods are useful for solving complex problems that involve numerous factors, such as the design of complex studies.
Clinical application of biomarkers and pharmacogenomics data
We are experts in the clinical application of biomarkers and pharmacogenomics (PGx). We help you integrate these data into clinical development, evaluate your portfolio to find opportunities for these data, design experiments, analyse data and provide information on how to use the results. We also work with you to enable the integration of these data into your research programs.
Other clinical data analysis support
We also provide analysis support for the following study types and activities: epidemiology; pre-clinical studies; translational medicine; experimental medicine; medical devices; pharmacovigilance; in-licensing support; and training, education and consultancy.
Biomarker data management, visualisation and analysis tools
Exploristics has partnered with OmicSoft Corporation to supply and distribute biomarker data management, visualisation and analysis tools in Europe. OmicSoft has designed software that is easy to use for the bench scientists, but powerful enough to be used by the bioinformatician or statistician. Exploristics offers two software packages: Array Studio and Array Server.
Statistics and visualisation for biomarker data analysis
Array Studio provides state-of-the-art statistics and visualisation for the analysis of high dimensional data. Array Studio supports all popular microarray platforms (Affymetrix, Agilent, Illumina, etc.), as well as SNP / genotype platforms (Affymetrix, Illumina, etc.) and CNV platforms (Affymetrix, Illumina and Agilent). Array Studio provides a full workflow for importing and normalisation of data, quality control, analysis, and clustering and pattern analysis.
Microarray / SNP / copy number variation (CNV) project integration
Array Server is an enterprise solution, allowing users to store, share, search and integrate their microarray / SNP / CNV projects. Array Server supports any number of high dimensional platforms, including the same platforms supported by Array Studio. Users can search by meta data, use search-by-gene functions, and can even profile gene regions across multiple studies.
Products and Services
Bydureon® BCise™ for the Treatment of Type-2 Diabetes
Bavencio (avelumab) for the Treatment of Metastatic Merkel Cell Carcinoma
Mydayis for the Treatment of Attention Deficit Hyperactivity Disorder
Rydapt (midostaurin) for the Treatment of Acute Myeloid Leukaemia and Systemic Mastocytosis
Ingrezza (valbenazine) for the Treatment of Tardive Dyskinesia
Translarna (ataluren) for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
Kisqali® (ribociclib) for the Treatment of HR+/HER2- Metastatic Breast Cancer
Trulance™ (Plecanatide) for the Treatment of Adults with Chronic Idiopathic Constipation (CIC)
Spinraza (nusinersen) for the Treatment of Spinal Muscular Atrophy (SMA)
Xultophy 100/3.6 for the Treatment of Type 2 Diabetes
Vemlidy (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection
Zinplava (bezlotoxumab) for the Treatment of Clostridium Difficile Infection
Invokamet XR for the Treatment of Type 2 Diabetes in Adults
Defitelio (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease
Descovy (emtricitabine, tenofovir alafenamide) for the Treatment of HIV-1 Infection
Xeljanz XR (tofacitinib citrate) Modified Release Tablets For the Treatment of Rheumatoid Arthritis
Briviact (brivaracetam) For the Treatment of Partial Onset Seizures
Portrazza (necitumumab) for the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Exploristics, the innovative data analysis and modelling company, is pleased to announce that is has received a grant from Invest NI to develop a simulation tool to optimise the design of research programmes for personalised medicine. This tool will enable users to: Maximise the liRead more
Exploristics, the innovative analysis group, is pleased to announce that Anaxsys has received the CE mark for its respiratory rate monitor, respiR8, from the British Standards Institute (BSI). This device provides the continuous monitoring of respiratory rate in post-operative recovery and offersRead more
Exploristics is pleased to announce an agreement with OmicSoft Corporation. Under the terms of the agreement, Exploristics will act as the sole distributor in Europe of OmicSoft's software products. Omicsoft focuses on biomarker data management, visualisation, and analysis. To achieve tRead more
Exploristics provides effective solutions to the challenge of managing, storing, integrating and analysing large volumes of biomarker data. Exploristics' recently released white paper, 'Management and Analysis of Biomarker Data', outlines how these solutions enable researchers to build their own,Read more
Exploristics is pleased to announce a collaboration with Cytos Biotechnology, the drug discovery, development and commercialisation company specialising in therapeutic vaccines. As part of the collaboration, Exploristics will perform exploratory data analysis to extract information from Cytos' daRead more
Exploristics, the innovative data analysis company, is pleased to announce the release of a new service that helps clinical researchers from across the healthcare sector to design and validate rating scales and quality of life instruments. We have developed and implemented a novel method that canRead more
Exploristics, the innovative data analysis company, is pleased to announce a new service that helps pharmaceutical and biotechnology companies identify and exploit new opportunities within their clinical development portfolios. Exploristics has implemented tools that use existing clinicRead more
Technical Paper on the Identification of Opportunities for Pharmacogenetics is Now Available from Exploristics
There is increasing demand in the pharmaceutical industry, in medical practice and by regulatory authorities to use new data, such as genetics, to identify patients who are likely to respond to treatment. Indeed, there has been some success with the clinical application of pharmacogenetics (PGx).Read more